In a 54-year-old woman presenting with initial urinary tract infection symptoms and a urine culture growing 3,000 colony‑forming units per milliliter yeast, should she be treated for candiduria or for a typical bacterial urinary tract infection?

Treatment of Candiduria in a Symptomatic 54-Year-Old Woman

Yes, treat this patient with oral fluconazole 200 mg daily for 2 weeks, assuming the yeast is fluconazole-susceptible (most likely Candida albicans). 1

Rationale for Treatment

This 54-year-old woman presents with symptomatic UTI and documented candiduria (3,000 CFU/mL yeast). The presence of urinary symptoms fundamentally changes the management approach compared to asymptomatic candiduria.

Key Decision Points:

Symptomatic vs. Asymptomatic Status:

• The IDSA 2016 guidelines clearly distinguish between these two scenarios 1
• In asymptomatic patients, candiduria almost always represents colonization and does not require treatment 1
• Multiple studies confirm that asymptomatic candiduria does not lead to candidemia and treatment does not improve mortality 1
• However, symptomatic patients with UTI symptoms and documented candiduria should be treated 1

Colony Count is NOT Determinative:

• The 3,000 CFU/mL count should not guide your decision 1
• The guidelines explicitly state that colony counts "cannot be used to define infection" and are particularly unreliable in differentiating colonization from true infection 1
• Clinical symptoms are what matter, not the quantitative culture result

Treatment Algorithm

First-Line Therapy:

Oral fluconazole 200 mg daily for 2 weeks (strong recommendation) 1

• This assumes fluconazole-susceptible organisms (most Candida albicans and many other species)
• Fluconazole achieves excellent urinary concentrations and is the only antifungal proven effective in a randomized controlled trial 1
• Available orally, making outpatient treatment feasible

Alternative Regimens (if fluconazole cannot be used):

For fluconazole-resistant C. glabrata:

• Amphotericin B deoxycholate 0.3–0.6 mg/kg IV daily for 1–7 days, OR
• Oral flucytosine 25 mg/kg four times daily for 7–10 days 1

For C. krusei:

• Amphotericin B deoxycholate 0.3–0.6 mg/kg IV daily for 1–7 days 1

Critical Caveats:

Do NOT use:

• Echinocandins (caspofungin, micafungin, anidulafungin) - they achieve inadequate urinary concentrations 1
• Lipid formulations of amphotericin B - insufficient urine levels 1
• Other azoles besides fluconazole - poor urinary excretion 1

Important considerations:

• Obtain species identification and susceptibilities when available
• Remove any indwelling urinary catheter if present (strong recommendation) 1
• Evaluate for urinary tract obstruction, which requires elimination 1
• Consider imaging if symptoms persist beyond 72 hours to rule out abscess, fungus ball, or pyelonephritis 1

Common Pitfalls to Avoid

1. Don't dismiss candiduria as "just colonization" in symptomatic patients - while true for asymptomatic patients, symptomatic candiduria with UTI symptoms warrants treatment 1

2. Don't use bacterial UTI antibiotics alone - if yeast is the only organism isolated and symptoms persist, antifungal therapy is needed

3. Don't use inadequate antifungals - many newer agents don't achieve urinary concentrations sufficient for treatment 1

4. Don't ignore risk factors - this 54-year-old woman may have diabetes, recent antibiotics, or catheter use that should be addressed 1, 2

5. Don't forget to consider mixed infection - ensure bacterial pathogens aren't also present requiring concurrent antibacterial therapy

Special Populations Requiring Aggressive Treatment

Even if asymptomatic, certain high-risk groups require treatment 1:

• Neutropenic patients
• Very low birth weight neonates
• Patients undergoing urologic instrumentation (treat periprocedurally)

Your patient doesn't fall into these categories, but her symptomatic presentation alone justifies treatment.